marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Catalyst Pharmaceuticals Balance Sheet 2011-2024 | CPRX
Annual Balance Sheet Catalyst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-134 M | -295 M | -167 M | - | -88.6 M | -16.6 M | -57.5 M | -13.9 M | -28.2 M | -9.1 M | -2.22 M | -1.41 M | -6.03 M |
Long Term Debt |
3.19 M | 3.56 M | 3.89 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
369 K | 337 K | 308 K | 28.8 K | 301 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 648 K | 155 K | 157 K | 303 K | 1.18 M | 2.81 M | 1.84 M | 520 K | 1.65 M |
Total Current Liabilities |
76.1 M | 57.6 M | 27.1 M | 22.8 M | 24.1 M | 9.51 M | 4.27 M | 2.09 M | 3.44 M | 5.86 M | 2.14 M | 1.65 M | 834 K |
Total Liabilities |
82.2 M | 75.2 M | 31 M | 22.8 M | 24.7 M | 9.67 M | 4.42 M | 2.4 M | 4.63 M | 8.67 M | 3.98 M | 2.17 M | 2.49 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
121 M | 49.9 M | -26.3 M | -53.7 M | -129 M | -161 M | -127 M | -108 M | -90.1 M | -69.8 M | -54.3 M | -42.2 M | -38.1 M |
Total Assets |
470 M | 376 M | 238 M | 192 M | 112 M | 60.4 M | 85.4 M | 41.7 M | 60.1 M | 43.9 M | 25.4 M | 16.8 M | 6.25 M |
Cash and Cash Equivalents |
138 M | 298 M | 171 M | 130 M | 89.5 M | 16.6 M | 57.5 M | 13.9 M | 28.2 M | 9.1 M | 2.22 M | 1.41 M | 6.03 M |
Book Value |
388 M | 300 M | 207 M | 170 M | 87.6 M | 50.8 M | 81 M | 39.3 M | 55.5 M | 35.2 M | 21.4 M | 14.6 M | 3.76 M |
Total Shareholders Equity |
388 M | 300 M | 207 M | 170 M | 87.6 M | 50.8 M | 81 M | 39.3 M | 55.5 M | 35.2 M | 21.4 M | 14.6 M | 3.76 M |
All numbers in USD currency
Quarterly Balance Sheet Catalyst Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.89 M | 2.99 M | 3.09 M | 3.19 M | 3.28 M | 3.38 M | 3.47 M | 3.56 M | 3.64 M | 3.73 M | 3.81 M | 3.89 M | 3.97 M | 4.05 M | 4.13 M | - | - | - | 568 K | 648 K | 648 K | 648 K | 648 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
111 M | 97.7 M | 85.3 M | 82.2 M | 64.7 M | 68.6 M | 73.6 M | 75.2 M | 63.1 M | 26.2 M | 26.8 M | 31 M | 24.6 M | 20.2 M | 18.6 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 24.7 M | 24.7 M | 24.7 M | 24.7 M | 9.67 M | 9.67 M | 9.67 M | 9.67 M | 4.42 M | 4.42 M | 4.42 M | 4.42 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 4.63 M | 4.63 M | 4.63 M | 4.63 M | 8.67 M | 8.67 M | 8.67 M | 8.67 M | 3.98 M | 3.98 M | 3.98 M | 3.98 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 2.49 M | 2.49 M | 2.49 M | 2.49 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
229 M | 185 M | 145 M | 121 M | 86.4 M | 117 M | 79.4 M | 49.9 M | 24.4 M | 1.64 M | -15.6 M | -26.3 M | -32.5 M | -37.8 M | -46.3 M | -53.7 M | -53.7 M | -53.7 M | -53.7 M | -129 M | -129 M | -129 M | -129 M | -161 M | -161 M | -161 M | -161 M | -127 M | -127 M | -127 M | -127 M | -108 M | -108 M | -108 M | -108 M | -90.1 M | -90.1 M | -90.1 M | -90.1 M | -69.8 M | -69.8 M | -69.8 M | -69.8 M | -54.3 M | -54.3 M | -54.3 M | -54.3 M | -42.2 M | -42.2 M | -42.2 M | -42.2 M | -38.1 M | -38.1 M | -38.1 M | -38.1 M |
Total Assets |
772 M | 706 M | 647 M | 470 M | 413 M | 444 M | 407 M | 376 M | 333 M | 267 M | 247 M | 238 M | 223 M | 209 M | 197 M | 192 M | 192 M | 192 M | 192 M | 112 M | 112 M | 112 M | 112 M | 60.4 M | 60.4 M | 60.4 M | 60.4 M | 85.4 M | 85.4 M | 85.4 M | 85.4 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M | 60.1 M | 60.1 M | 60.1 M | 60.1 M | 43.9 M | 43.9 M | 43.9 M | 43.9 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M |
Cash and Cash Equivalents |
442 M | 376 M | 310 M | 138 M | 121 M | 179 M | 148 M | 298 M | 256 M | 211 M | 178 M | 171 M | 155 M | 135 M | 127 M | 130 M | 130 M | 130 M | 130 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 57.5 M | 57.5 M | 57.5 M | 57.5 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 6.03 M | 6.03 M | 6.03 M | 6.03 M |
Book Value |
661 M | 609 M | 561 M | 388 M | 349 M | 375 M | 334 M | 300 M | 270 M | 241 M | 220 M | 207 M | 199 M | 189 M | 179 M | 170 M | 170 M | 170 M | 170 M | 87.6 M | 87.6 M | 87.6 M | 87.6 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 81 M | 81 M | 81 M | 81 M | 39.3 M | 39.3 M | 39.3 M | 39.3 M | 55.5 M | 55.5 M | 55.5 M | 55.5 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M |
Total Shareholders Equity |
661 M | 609 M | 561 M | 388 M | 349 M | 375 M | 334 M | 300 M | 270 M | 241 M | 220 M | 207 M | 199 M | 189 M | 179 M | 170 M | 170 M | 170 M | 170 M | 87.6 M | 87.6 M | 87.6 M | 87.6 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 81 M | 81 M | 81 M | 81 M | 39.3 M | 39.3 M | 39.3 M | 39.3 M | 55.5 M | 55.5 M | 55.5 M | 55.5 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M |
All numbers in USD currency